| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Chief Financial Officer
1 company
Cline Christopher R. serves as a Chief Financial Officer at TVTX. Across recent SEC filings that breaks down to 0 buys and 23 sells. Those positions are worth an estimated $7.0M at current prices.
Historically, Cline Christopher R.'s trades have earned a below-average insider score of 48/100 across 22 rated trades. Over a 12-month horizon, 35.7% of those trades were profitable, with an average 12-month return of -36.2%.
The biggest single holding is TVTX (~$7.0M) as Chief Financial Officer. The recent filings there lean toward selling, a net 55,629 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 15, 2026 | TVTX Travere Therapeutics, Inc. | Chief Financial Officer | Sell | 8,327 | $41.91 | $348,974.00 | -1.7% | +39.3% | - | |
| Feb 3, 2026 | TVTX Travere Therapeutics, Inc. | Chief Financial Officer | Sell | 7,242 | $32.12 | $232,613.04 | -6.0% | +34.3% | - | |
| Dec 1, 2025 | TVTX Travere Therapeutics, Inc. | Chief Financial Officer | Sale+OE | 20,000 | $35.01 | $700,202.00 | -17.8% | -16.1% | - | |
| Sep 4, 2025 | TVTX Travere Therapeutics, Inc. | Chief Financial Officer | Sell | 573 | $18.51 | $10,608.29 | -0.3% | +64.8% | - | |
| Aug 27, 2025 | TVTX Travere Therapeutics, Inc. | Chief Financial Officer | Sell | 470 | $17.31 | $8,135.70 | -0.5% | +106.5% | - | |
| May 5, 2025 | TVTX Travere Therapeutics, Inc. | Chief Financial Officer | Sale+OE | 1,784 | $21.05 | $37,553.20 | -1.9% | -25.5% | +109.2% | |
| Apr 11, 2025 | TVTX Travere Therapeutics, Inc. | Chief Financial Officer | Sell | 48 | $13.14 | $630.94 | - | +14.1% | +99.7% | |
| Feb 3, 2025 | TVTX Travere Therapeutics, Inc. | Chief Financial Officer | Sell | 5,192 | $20.12 | $104,463.04 | -5.5% | +5.9% | +62.4% | |
| Jan 22, 2025 | TVTX Travere Therapeutics, Inc. | Chief Financial Officer | Sell | 865 | $18.94 | $16,383.88 | -1.2% | -18.4% | +52.8% | |
| Sep 9, 2024 | TVTX Travere Therapeutics, Inc. | Chief Financial Officer | Sell | 2,490 | $11.52 | $28,684.80 | -3.2% | +46.0% | +68.3% |